By fusing an oxygen-sensitive subdomain of HIF1α to a CAR scaffold, CAR-T cells that are locally responsive to a hypoxic environment can be generated, which could be a promising therapeutic approach for restoring T cell function during cancer (173). This evidence concerns the gene HIF1A and cancer.